Search

everythinglearnresearchcommunity

for

Search:↓

The human hair follicle can store topical compounds and be targeted for drug delivery with minimal side effects.

Different body areas in mice produce different hair types due to interactions between skin layers.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Some breast cancer chemotherapy can cause permanent hair loss.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Lower hair zinc and copper levels found in Turkish males with hair loss; higher BMI linked to less hair zinc.

Using anabolic-androgenic steroids can cause skin problems like acne and hair loss in athletes.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Low-dose oral minoxidil improved or stabilized hair loss in some patients, but higher doses may be needed for significant effects.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

The new classification system for skin disorders emphasizes the importance of understanding a patient's awareness of their condition for better treatment.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

People undergoing chemotherapy need better support and information to cope with hair loss.

The perception of excessive hair growth in women as abnormal is more influenced by cultural norms than by medical reasons.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Hair transplantation can help transgender patients affirm their gender identity.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

Hair transplantation techniques have improved over 12 years, with follicular unit grafting providing more natural results and potential future advances in automation and genetics.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.